Despite we first propose that mutations of IGLL5 and LRP1B were significantly related to the survival of pGI-DLBCL patients, there is still a lack of detailed information on how the mutations affect their expression and/or functional role. This evidence concerns the gene IGLL5 and diffuse large B-cell lymphoma.